SEARCH
« Study shows dogs will go out of their way to help owners in emotional distress | Main | Pediatricians raise concern about health effects of some food coloring, additives »
Wednesday
Jul252018

Bayer to no longer sell permanent birth control implant Essure 

BayerBY: DR. STEPHANIE SOPHIE LEE

(NEW YORK) -- Bayer Pharmaceuticals announced that it will no longer sell the permanent birth control implant Essure starting at the end of this year.

Essure has courted controversy since it hit the market in 2002. It was initially marketed as the only permanent birth control method that did not require a surgical incision.

Earlier this year, the U.S. Food and Drug Administration (FDA) announced that patients must be given an in-depth checklist prior to receiving the implant.

“We’ve been closely evaluating new information on the use of Essure, and based on our review of a growing body of evidence, we believe this product requires additional, meaningful safeguards to ensure women are able to make informed decisions about risk when considering this option,” FDA Commissioner Scott Gottlieb said in a statement in April.

Women who say they have experienced adverse side effects from the contraceptive have also convened in a series of Facebook groups -- some of which have exploded in popularity -- where they share their experiences and warn other women considering the procedure. Some groups have garnered tens of thousands of members.

On the Facebook pages, many women advocate against its use, citing pain and bleeding. In some cases, they reported experiencing perforation of the uterus or tubes after insertion.

Bayer has maintained that its decision to pull the product -- effective Dec. 31 -- was solely based on business reasons, citing declining sales in recent years.

In a statement to ABC News, Bayer said "the positive benefit-risk profile of Essure has not changed and has been demonstrated in extensive clinical trials, post-approval studies and analyses of real-world evidence over the past 20 years."

The statement added that the "FDA continues to believe that Essure’s benefit-risk profile remains positive and unchanged."

To receive the implant, a health care provider inserts a small implant made of flexible coils via a video-assisted device through the vagina into the fallopian tubes, the tubes that carry eggs to the uterus, or womb.

After a few months, scar tissue develops as a barrier to prevent the eggs from ever meeting sperm and the woman from becoming pregnant.

Dr. Ronald Johnson, an assistant professor of obstetrics and gynecology (OB-GYN) at Loma Linda University School of Medicine, told ABC News that he has used it often in practice -- but not recently.

“I used it a significant amount, and it was a device that was well thought-out. The idea was quite sound. It had great efficacy,” he told ABC News, saying that all other options for permanent contraception are done by laparoscopic surgeries.

Laparoscopic surgery is a minimally invasive technique where small surgical incisions are made on the skin so that surgical tools with cameras can be inserted to navigate inside the abdomen.

Patients who benefited from Essure were usually those who couldn’t have abdominal surgeries, such as people with morbid obesity, multiple prior surgeries or other internal abdominal issues.

“It was a very clever tool to have in our quiver,” Johnson added. “If the protocols were followed properly, it had a group of patients it was uniquely advantageous to.”

However, Johnson said he believes complications were more often from improper practitioner use rather than the Essure device itself, because of procedure complexity.

In fact, he described one woman where an unknown provider had inserted multiple devices in both tubes because, presumably, the provider had been unable to see the originals and thought the woman needed more. Unfortunately, the device had actually gone through the walls of her uterus and tubes.

“From about 2002 to 2016, I never had a single person come back complaining of pain or requesting removal," Johnson said. "But, in the last year and a half, I’ve removed five or six."

Johnson said he's unsure if it's internet awareness or an actual association of the device with problems, but from his experience, the "vast majority work without a complication,” which is consistent with patient satisfaction ratings from FDA clinical trial participants after five years, according to the statement from Bayer.

For those who do end up having complications, removal may be the answer. However, people should speak with their physicians about it.

Copyright © 2018, ABC Radio. All rights reserved.







ABC News Radio